Vaccination against typhoid in adults and children aged two years and over.
Typhim (Typhoid) PFS 0.5ml (1) *POM*
£22.39 + VAT
THIS PRODUCT IS A RESTRICTED ITEM. CONTACT US FOR MORE INFORMATION
Availability: In stock
£22.39 + VAT
RELATED ITEMS
Hemotrol Low – Level 1 (2 Vials)
£37.72 + VAT
VAQTA Adult Hep A Vaccine PFS – 1ml (1) *POM*
£65.75 + VATVAQTA is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.
Yellow Fever Vaccine (1) *POM*
£83.39 + VATIndicated for active immunization against yellow fever in persons: Travelling to, passing through or living in an endemic area Travelling to any country that requires an International Certificate of Vaccination for entry (which may or may not depend on the...
Engerix B Vial (Hepatitis B) – 20mcg/1ml (10) *POM*
£405.43 + VATEngerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects. The 20 µg dose vaccine in 1.0 ml suspension is intended for use in subjects 16 years of age and above.
Dukoral – Oral Cholera Vaccine (2 Vial & 2 Sachets) *POM*
£72.59 + VATDUKORAL is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children from 2 years of age who will be visiting endemic/epidemic areas.
Ixiaro Jap B Encephalitis Syringe – 0.5ml *POM*
£172.32 + VATIXIARO is indicated for active immunization against Japanese encephalitis in adults.IXIARO should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.
Havrix Monodose (Hepatitis A) PFS – 1ml (1) *POM*
£75.97 + VATActive immunisation against infections caused by hepatitis A virus. The vaccine is particularly indicated for those at increased risk of infection or transmission.Twinrix Vaccine Adult – 1ml (10) *POM*
£535.75 + VAT
Avaxim (Hepatitis A) PFS – 0.5ml (10) *POM*
£657.24 + VATAVAXIM is indicated for active immunisation against infection caused by hepatitis A virus in susceptible adults and adolescents of 16 years of age and above.
